Biomea Fusion Inc (BMEA) Sector
Health Care

(Current) $10.67
-0.46 (-4.13%) Open Price: 11.00

 

Biomea Fusion Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for patients with genomically defined cancers. Founded in 2018 and based in South San Francisco, California, the company has quickly emerged as a key player in the field of precision oncology, aiming to address unmet medical needs through its innovative pipeline of therapies.

 

At the heart of Biomea Fusion's approach is its dedication to identifying and targeting gene fusions that drive the growth of certain cancers. Gene fusions are genetic abnormalities that result from the abnormal joining of two different genes, leading to the production of abnormal proteins that can fuel cancer growth. Biomea Fusion's therapies are designed to selectively inhibit these abnormal proteins, thereby disrupting the cancer's growth signals.

 

The company's pipeline includes a range of investigational therapies in various stages of development. These therapies target specific gene fusions implicated in different types of cancers, including solid tumors and hematologic malignancies. By focusing on the underlying genetic drivers of cancer, Biomea Fusion aims to create more effective and personalized treatment options for patients.

 

Biomea Fusion places a strong emphasis on precision medicine and patient-centricity. The company's goal is to develop therapies that provide meaningful clinical benefits to patients while minimizing adverse effects. This patient-centered approach is reflected in its commitment to rigorous clinical research and development.

 

The company's progress has been recognized by collaborations and partnerships with other biopharmaceutical companies, research institutions, and healthcare organizations. These collaborations aim to leverage the collective expertise and resources of the industry to accelerate the development of innovative therapies.

 



 

(05/24/24) $11.00
(05/27/24) $11.13
(05/27/24) (Qty.)1,054,171
(05/24/24) $10.73
(05/24/24) $11.61
(05/05/24) $10.61
(05/12/24) $13.43
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing